Replicate Bioscience will partner with Novo Nordisk to develop treatments using self-replicating RNA technology for obesity, type 2 diabetes and other cardiometabolic diseases, the privately held ...

As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline.  | As obesity ...

Novo Nordisk has brought on other cardiometabolic collaborators this year, including United Laboratories International and Deep Apple Therapeutics.

The agreement provides research funding for Replicate and up to $550M in payments to develop medicines for diseases including obesity and diabetes.

The Velotric Nomad 2 has Apple Health, Find My, a 750W motor, fat 26-inch tires, 65 miles of range, and the ability to swap between torque and cadence modes. It's an incredible e-bike for its size and ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

Federal regulators warn that dashboard panel failures prevent drivers from seeing critical speed and warning information.

Other technology challenges include the need for investment in digital commerce, the implementation of artificial intelligence and the need to invest in cybersecurity. Patterson noted that drug stores ...